Abstract:Objective Glucocorticoid (GC) is the principal therapeutic drug in the treatment of idiopathic nephrotic syndrome (INS), and the response to GC treatment is an important indicator for the outcome of INS children. Children with GC-resistant INS are usually incompletely or non responseive to GC, and may herald the progression to end-stage renal failure. However, the detailed mechanism for why some INS children respond to GC and others do not, have still not been clearly elucidated. It is well known that GC action is mediated by the GC receptor (GR), a ligand-dependent transcription factor that belongs to the super-family of nuclear receptors. Two human GR isoforms termed GR α and GR β have been described. Recent studies demonstrated that the β-isoform of GR (GR β) is a potential endogenous inhibitor of the GC action in humans. So far, no research papers have involved in the relationship between the levels of two GR isoforms, GR α and GR β, expression in INS children and the response to GC in INS children. The aim of the present study was to determine the levels of GR α and GR β in INS children with the variable response to the GC treatment. Methods Twenty patients aged 4～13 years with INS were classified as GC-sensitive INS (8 patients) or GC-resistant INS (12 patients), according to their response to an eight-week course of oral prednisone. The heparinized venous blood was collected, and peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque gradient centrifugation. The immunocytochemical assay was used to investigate the expression of two isoforms of GR in PBMC. The cytoplasm protein and nuclear protein extracts from PBMC were obtained, and the quantity of GR α and GR β proteins were analyzed by Western blotting assay. Then the GR-DNA-binding activity was detected by electrophoretic mobility shift assay (EMSA). Results The two isoforms of GR were expressed in PBMC in INS and healthy children. The percentages of GR αpositive staining cells in GC-resistance INS and GC-sensitive INS were significantly lower than that in healthy children (P0.01), but no significant difference was found between two INS groups. However, the number of GR β positive staining cells in GC-resistant INS was significantly higher than that in GC-sensitive INS (P0.01). Results of Western blots assay identified the presence of only one specific protein band at the expected molecular weight 94 000 or 90 000, which was consistent with those of GR α and GR β, respectively. In GC-resistant INS children, the quantity of GR α protein in GC-resistant INS group was significantly higher in the cytoplasm, and significantly lower in the nuclei, while the quantity of GR β protein in the nuclei was significantly higher than that of GC-sensitive INS, respectively. The results of EMSA showed that GR-DNA-binding activity in GR-resistant INS group was decreased compared to GR-sensitive INS group. Conclusions The patients with GC-resistant INS have an increased expression of GR β. The imbalanced expression between GR α and GR β, especially increased expression of GR β in PBMC might account for GC-resistant INS. GR β might antagonize GC-mediated GR α function by prohibiting the GR α translocation into the nuclei and depressing GR-DNA binding activity. This finding suggests that GR β might be a critical factor regulating the responsiveness of the target cell to GC. The ability of GR β to repress the action of GR α also illustrates a new insight to the satisfactory explanation of why some INS children respond to GC and others do not.

The expression and clinical implications of glucocorticoid receptor α and β mRNA in peripheral blood mononuclear cells in children with infantile spasms

Expression of GRα, GRβ in Peripheral Blood Mononuclear Cells in Patients with Primary Nephrotic Syndrome and Its Clinical Significance

Epigenetic Regulation of Glucocorticoid Receptor and Infantile Spasms.

Upregulations of CRH and CRHR1 in the Epileptogenic Tissues of Patients with Intractable Infantile Spasms

Changes and Significance of Glucocorticoid Receptor β and Heat Shock Proteins 90 in Peripheral Blood in Children with Primary Nephritic Syndrome

Significance of Α-and Β-Isoforms of Glucocorticoid Receptors Expression in Children with Idiopathic Nephrotic Syndrome

Effects of splicing factor SRp40 on the expression of GRα/β mRNA and on glucocorticoid therapy for nephrotic syndrome

Expression of glucocorticoid receptors in children with idiopathic thrombocytopenic purpura

Application of peripheral blood cytokine and immunoglobulin detection in ACTH therapy for the treatment of infantile spasms

NR3C1 Gene Polymorphism for Genetic Susceptibility to Infantile Spasms in a Chinese Population

[Effect of Glucocorticoid on Glucocorticoid-Resistant Children with Primary Nephrotic Syndrome].

Expressions of Multiple Drug-Resistant Gene 1 and Permeability-Glycoprotein 170 in Peripheral Blood Mononuclear Cell in Children with Primary Nephrotic Syndrome

Retrospective study of different doses of ACTH therapy for infantile spasms

Increased Expression of the Glucocorticoid Receptor β in Infants With RSV Bronchiolitis

Study on expression of glucocorticoid receptor(GR)α in the peripheral blood leucocytes in unipolar and bipolar depressive disorders

Analysis of Single Nucleotide Polymorphisms in the Melanocortin-4 Receptor Promoter in Infantile Spasms

A possible association of responsiveness to adrenocorticotropic hormone with specific GRIN1 haplotypes in infantile spasms: Polymorphisms in GRIN1 in Infantile Spasms

Research on the expressions of multiple drug-resistant gene in peripheral blood mononuclear cells of children with nephrotic syndrome

Correlation Study Between Genetic Polymorphisms of Melanocortin Receptors and Adrenocorticotropic Hormone Responsiveness in Infantile Spasms

Relationship Between Expression Level of Glucocorticoid Receptor and Treatment Outcome in Children with Acute Lymphoblastic Leukemia

Influencing Factors of Infantile Spasms Relapse after Remission